For instance, an increase in Stim1 and Orai1 transcripts and proteins has been described in oestrogen receptor-negative human breast cancer cell lines [56], while TRPC1 up-regulation in these cells is still controversial [56], [57]. Here, STIM1 is linked to breast carcinoma.